Abtak Logo

neovascularization News

Stay updated with the latest neovascularization news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on neovascularization topics.

NewsDrum - Business - News Image
soure image
18
BusinessAug 12, 2025 01:10 PM

Lupin ties up with Sandoz to commercialise biosimilar product

New Delhi, Aug 12 (PTI) Drug firm Lupin on Tuesday said it has partnered with Switzerland-based Sandoz Group AG to commercialise its biosimilar ranibizumab across multiple regions. Under the terms of the agreement, Sandoz will oversee commercialisation of the product across the European Union (excluding Germany), Switzerland, Norway, Australia, Hong Kong, Vietnam, and Malaysia, the Mumbai-based drug maker said in a statement. Lupin will be responsible for manufacturing the product and for regu ...Read More >

NewsDrum - Business Health - News Image
soure image
30
BusinessHealthJun 27, 2025 01:17 PM

Biocon Biologics gets Health Canada nod for biosimilar Yesafili

New Delhi, Jun 27 (PTI) Biocon Ltd on Friday said its arm Biocon Biologics has been granted a notice of compliance by Health Canada for its biosimilar Yesafili injection used to treat various ailments of the eye. "Health Canada has granted a Notice of Compliance (NOC) for Yesafili(aflibercept), a biosimilar to Eylea injection, in vial and prefilled syringe presentations, 2 mg/0.05 mL on June 26, 2025," a regulatory filing by Biocon said. This approval paves the way for the launch of Yesafili i ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.